Preventing CMV in Stem Cell Transplant Patients

Review the latest expert guidance in this comprehensive program on the prevention and management of cytomegalovirus in hematopoietic cell transplant recipients, which features a module with expert answers to frequently asked questions and an interactive case challenge.

Roy F. Chemaly, MD

Interactive Case Challenge

Case Challenge

Preventing and Managing Cytomegalovirus in High-Risk Hematopoietic Cell Transplantation Patients: Interactive Case Challenge

View Case Challenge

In this Interactive Case Challenge, explore important considerations in CMV prophylaxis and treatment in patients who have undergone hematopoietic cell transplantation.

Roy F. Chemaly, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: February 26, 2019 Expired: No longer available for credit

Provided by Postgraduate Institute for Medicine.

Contact Info

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from

Merck & Co., Inc.

Preventing CMV in Stem Cell Transplant Patients

Interactive Case Challenge

Preventing and Managing Cytomegalovirus in High-Risk Hematopoietic Cell Transplantation Patients: Interactive Case Challenge

Leaving the CCO site